Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Total Current Liabilities: 2023-2025

Historic Total Current Liabilities for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Sep 2025 value amounting to $21.0 million.

  • Tonix Pharmaceuticals Holding's Total Current Liabilities rose 38.54% to $21.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.0 million, marking a year-over-year increase of 38.54%. This contributed to the annual value of $18.3 million for FY2024, which is 3.06% down from last year.
  • According to the latest figures from Q3 2025, Tonix Pharmaceuticals Holding's Total Current Liabilities is $21.0 million, which was up 10.34% from $19.1 million recorded in Q2 2025.
  • Tonix Pharmaceuticals Holding's 5-year Total Current Liabilities high stood at $22.0 million for Q2 2024, and its period low was $12.1 million during Q1 2025.
  • In the last 3 years, Tonix Pharmaceuticals Holding's Total Current Liabilities had a median value of $18.4 million in 2023 and averaged $17.9 million.
  • In the last 5 years, Tonix Pharmaceuticals Holding's Total Current Liabilities skyrocketed by 56.65% in 2024 and then slumped by 40.69% in 2025.
  • Tonix Pharmaceuticals Holding's Total Current Liabilities (Quarterly) stood at $18.9 million in 2023, then fell by 3.06% to $18.3 million in 2024, then skyrocketed by 38.54% to $21.0 million in 2025.
  • Its Total Current Liabilities stands at $21.0 million for Q3 2025, versus $19.1 million for Q2 2025 and $12.1 million for Q1 2025.